![Leonid Beigelman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leonid Beigelman
No open positions remaining
Profile
Leonid N.
Beigelman was the founder of Alios BioPharma, Inc. founded in 2008, where he held the title of Chief Scientific Officer from 2012 to 2014.
He held former positions as Senior Director-Chemistry & Biochemistry at Sirna Therapeutics, Inc. from 1992 to 2002, Vice President-Nucleic Acids Chemistry at Transgenomic, Inc. from 2002 to 2005, Vice President-Technical Operations at InterMune, Inc. from 2005 to 2009, and VP-Medicinal Chemistry & Global Head-Discovery at Johnson & Johnson from 2014 to 2018.
He also worked as a Research Scientist at United States Biochemical Corp.
Dr. Beigelman earned a doctorate degree from the Institute of Molecular Biology.
Former positions of Leonid Beigelman
| Companies | Position | End |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | President | 2023-11-30 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 2018-02-28 |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Founder | 2014-10-31 |
| INTERMUNE INC | Corporate Officer/Principal | 2008-12-31 |
Transgenomic, Inc.
 Transgenomic, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine in the detection and treatment of cancer and inherited diseases | Corporate Officer/Principal | 2004-12-31 |
Training of Leonid Beigelman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Commercial Services |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Transgenomic, Inc.
Transgenomic, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine in the detection and treatment of cancer and inherited diseases | Health Technology |
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Health Technology |
United States Biochemical Corp.
 United States Biochemical Corp. Pharmaceuticals: OtherHealth Technology Medicinals & botanicals; drugs | Health Technology |
Institute of Molecular Biology
 Institute of Molecular Biology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
- Stock Market
- Insiders
- Leonid Beigelman
